The Use of Microsampling to Improve the Relevance of Toxicity Study Data

Microsampling provides the ability to relate toxicity directly to exposure in a single animal and obtain a full TK profile from that animal, allowing for a more accurate understanding of the toxicokinetics and the effect of exposure.

In this webinar we’ll discuss how increasingly complex study designs and assessment of pharmacologically active drugs in the animal model often requires the evaluation of many parameters/endpoints and how microsampling can also be used for the analysis of biomarkers and immunotoxicology assays.

Presenters

  • Alan Hoberman, PhD, Executive Site Director, Charles River
  • Karen Woods, PhD, Associate Principal Scientist, Translational Biomarkers and Bioanalysis, Drug Safety and Metabolism, AstraZeneca